How to reignite the fight against the nation’s opioid epidemic
The COVID-19 crisis is far from over, yet the opioid epidemic continues to flare. The AMA details steps states should take, and calls on CDC to revise its opioid prescribing guideline.
AMA COVID-19 daily video update: Experts discuss the pandemic’s impact on the opioid epidemic
The AMA is leading the fight against the COVID-19 pandemic. See the latest daily video update on how the COVID-19 pandemic has impacted the opioid epidemic.
Taking action on opioid use disorder, pain & harm reduction during COVID-19
Policy recommendations focused on pain, opioid use disorder (OUD) and harm reduction to help states during the COVID-19 epidemic.
New policies on treating pain, OUD emerge from COVID-19 crisis
The DEA is allowing qualified physicians to prescribe buprenorphine over the telephone so patients can stay home. The AMA urges states to do the same.
AMA urges governors to adopt DEA guidance for opioid use disorder
This guidance removes a considerable barrier for many patients during the COVID-19 national emergency and, importantly, allows them to stay at home.
COVID-19 policy recommendations for OUD, pain, harm reduction
The AMA provides policy recommendations to help guide policymakers reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.
New York effort raises use of MAT for opioid-use disorder
Medications for addiction treatment (MAT) are underused, with racial, geographic and economic barriers. Learn about a Big Apple initiative that’s making big changes.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights